Correction: Yalçın et al. Impact of SGLT2 Inhibitors on Cardiovascular Risk Scores, Metabolic Parameters, and Laboratory Profiles in Type 2 Diabetes. Life 2025, 15 , 722.

Saved in:
Bibliographic Details
Title: Correction: Yalçın et al. Impact of SGLT2 Inhibitors on Cardiovascular Risk Scores, Metabolic Parameters, and Laboratory Profiles in Type 2 Diabetes. Life 2025, 15 , 722.
Authors: Yalçın, Nazif1 (AUTHOR), Aktaş, Selman2 (AUTHOR), Uyar, Seyit3 (AUTHOR), Koca, Nizameddin1 (AUTHOR) nizameddin.koca@sbu.edu.tr
Source: Life (2075-1729). Jun2026, Vol. 16 Issue 6, p1021. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20751729
DOI:10.3390/life16061021